Panitumumab Chemoradiotherapy Chemotherapy for Squamous Cancer of the Head and Neck
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Amgen
Related studies linked through entity extraction aliases.
Strategies to Treat Osteoporosis Following a Fragility Fracture
- Status
- COMPLETED
- Phase
- NA
Phase 2 Study of AMG 386 Plus Paclitaxel With or Without Bevacizumab as First Line Therapy in Her2-Negative Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Phase 2 Study of Carfilzomib in Relapsed and Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Etanercept (Enbrel) for Juvenile Myelomonocytic Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
An Open Label Study of Romiplostim in Adult Thrombocytopenic Subjects With ITP
- Status
- COMPLETED
- Phase
- PHASE3
A Study of AMG 951 [rhApo2L/TRAIL] in Subjects With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) Treated With Chemotherapy +/- Bevacizumab
- Status
- COMPLETED
- Phase
- PHASE2
Panitumumab Plus FOLFIRI in First-line Treatment of Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Safety, Pharmacokinetic and Pharmacodynamic Study of MP-376 in Patients With Cystic Fibrosis
- Status
- COMPLETED
- Phase
- PHASE1
Tissue Repair in Stem Cell Transplant Recipients
- Status
- TERMINATED
- Phase
- NA
Study of Addition of Panitumumab to Chemoradiation Therapy in Patients With Locally Advanced Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase 2b Study of Taxol Plus Sorafenib or Placebo in Patients With Advanced Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
1st or 2nd Line MBC (Metastatic Breast Cancer) With Previous Avastin (Bevacizumab) Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Phase 2 AMG 386 in Comb. Paclitaxel for Subjects With Advanced Recurrent Epithelial Ovarian or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Effects of TNF-alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis
- Status
- TERMINATED
- Phase
- NA
Panitumumab in Combination With Irinotecan Chemotherapy as 2nd-line Therapy in Subjects With mCRC
- Status
- COMPLETED
- Phase
- PHASE2
Evaluating the Safety of Long Term Dosing of Romiplostim (Formerly AMG 531) in Thrombocytopenic Subjects With Myelodysplastic Syndromes (MDS)
- Status
- COMPLETED
- Phase
- NA
AMG 386, 20060159 Phase 2, RCC 1st Line in Combination With Sorafenib
- Status
- COMPLETED
- Phase
- PHASE2
MONET1-MOtesanib NSCLC Efficacy and Tolerability Study
- Status
- TERMINATED
- Phase
- PHASE3
Study of Panitumumab Efficacy in Patients With Recurrent and/or Metastatic Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE3